On October 22, 2020 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), reported that its third quarter 2020 financial results will be released after market close on Thursday, November 5, 2020 (Press release, Coherus Biosciences, OCT 22, 2020, View Source/news-releases/news-release-details/coherus-biosciences-report-third-quarter-financial-results-0" target="_blank" title="View Source/news-releases/news-release-details/coherus-biosciences-report-third-quarter-financial-results-0" rel="nofollow">View Source [SID1234568831]). Starting at 4:30 p.m. EST, Coherus’ management team will host a conference call to discuss financial results and provide a general business update .

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

After releasing third quarter financial results, the Company will post them on the Coherus website at View Source." target="_blank" title="View Source." rel="nofollow">View Source

Conference Call Information

When: Thursday, November 5, 2020 starting at 4:30 p.m. EST

Webcast: View Source

Dial-in: 844-452-6826 (Toll-Free U.S. and Canada) or 765-507-2587 (International)
Please dial-in 15 minutes early to ensure a timely connection to the call.

Conference ID: 7079429